AlphaB-crystallin and breast cancer: role and possible therapeutic strategies.


Journal

Cell stress & chaperones
ISSN: 1466-1268
Titre abrégé: Cell Stress Chaperones
Pays: Netherlands
ID NLM: 9610925

Informations de publication

Date de publication:
01 2021
Historique:
received: 06 08 2020
accepted: 20 10 2020
revised: 10 10 2020
pubmed: 29 10 2020
medline: 25 12 2021
entrez: 28 10 2020
Statut: ppublish

Résumé

AlphaB-crystallin (HSPB5) is one of the most prominent and well-studied members of the small heat shock protein (sHsp) family. To date, it is known that this protein modulates significant cellular processes and therefore, it is not surprising that its deregulation is involved in various human pathologies, including cancer diseases. Despite the pathogenic significance of HSPB5 in cancer and its regulatory mechanism related to aggressiveness is poorly understood, several reports describe the association of breast carcinoma progression with HSPB5, whose expression is also considered an independent predictor of breast cancer metastasis to the brain. Indeed, numerous authors indicate HSPB5 as a new valuable biomarker for clinicopathological parameters and poor prognosis in breast cancer. Considering the cytoprotective, anti-apoptotic, pro-angiogenic, and pro-metastatic properties of the sHsps, it is not surprising that they are considered as promising targets for anticancer treatment, even though, at present, a deeper understanding of their mode of action is needed to allow the development of precise therapeutic interventions. Data on the direct inhibition of different sHsps demonstrate promising results in cancer pathologies; however, specific strategies against HSPB5 have not been considered. This review highlights the most relevant findings on HSPB5 and its role in breast cancer, as well as the possible strategies in using HSPB5 inhibition for therapeutic purposes.

Identifiants

pubmed: 33111264
doi: 10.1007/s12192-020-01175-0
pii: 10.1007/s12192-020-01175-0
pmc: PMC7736448
doi:

Substances chimiques

Antineoplastic Agents 0
CRYAB protein, human 0
alpha-Crystallin B Chain 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-28

Références

Int J Mol Sci. 2017 Sep 15;18(9):
pubmed: 28914774
Cell Death Differ. 2004 May;11(5):512-26
pubmed: 14752512
Ann Oncol. 2017 Oct 1;28(10):2481-2488
pubmed: 28961845
Cell Stress Chaperones. 2014 Nov;19(6):963-72
pubmed: 24898092
Cell Stress Chaperones. 2005 Autumn;10(3):171-84
pubmed: 16184762
Cell Death Dis. 2011 Oct 20;2:e221
pubmed: 22012255
FASEB J. 2010 Oct;24(10):3633-42
pubmed: 20501794
Cell Stress Chaperones. 2018 Jul;23(4):491-505
pubmed: 29190034
Mol Cell Biol. 1993 Nov;13(11):7144-52
pubmed: 8413303
Biochem Biophys Res Commun. 2007 Mar 2;354(1):109-14
pubmed: 17222797
Br J Cancer. 2018 May;118(11):1434-1441
pubmed: 29765151
Free Radic Res. 2018 Jun;52(6):639-647
pubmed: 29589779
NPJ Breast Cancer. 2015 Oct 21;1:
pubmed: 27656679
BMC Med Genomics. 2017 Mar 28;10(1):19
pubmed: 28351365
Int J Mol Sci. 2019 Sep 17;20(18):
pubmed: 31533245
Biochim Biophys Acta. 2011 Aug;1813(8):1532-42
pubmed: 21640763
J Biol Chem. 2002 Oct 11;277(41):38731-6
pubmed: 12140279
Am J Physiol Cell Physiol. 2004 Mar;286(3):C713-22
pubmed: 14627610
J Mol Cell Cardiol. 1999 Mar;31(3):569-80
pubmed: 10198188
Cancers (Basel). 2014 Feb 07;6(1):333-65
pubmed: 24514166
Oncogene. 2015 Nov 5;34(45):5626-34
pubmed: 25684139
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Aug;32(4):660-4
pubmed: 17767061
Clin Cancer Res. 2007 Apr 15;13(8):2329-34
pubmed: 17438091
Ophthalmologica. 2000 Jan-Feb;214(1):7-12
pubmed: 10657740
Genomics. 1990 Aug;7(4):594-601
pubmed: 2387586
Oncotarget. 2016 Oct 18;7(42):68156-68169
pubmed: 27626687
Redox Biol. 2019 Jun;24:101183
pubmed: 30974319
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5995-6000
pubmed: 17389375
Int J Biol Markers. 2013 Dec 17;28(4):e365-70
pubmed: 23722303
Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):488-97
pubmed: 17255270
Nature. 1983 Mar 31-Apr 6;302(5907):415-7
pubmed: 6835373
J Pathol. 1994 Nov;174(3):209-15
pubmed: 7823254
Int J Biochem Cell Biol. 2012 Oct;44(10):1593-612
pubmed: 22750029
Breast Cancer Res Treat. 2014 May;145(1):45-59
pubmed: 24710637
Free Radic Biol Med. 2020 May 20;152:301-312
pubmed: 32224085
Hum Mol Genet. 2016 May 1;25(9):1677-89
pubmed: 26920069
Free Radic Biol Med. 2010 Aug 1;49(3):374-82
pubmed: 20441791
J Proteome Res. 2005 Sep-Oct;4(5):1610-8
pubmed: 16212413
Semin Cell Dev Biol. 2000 Feb;11(1):53-60
pubmed: 10736264
Hum Pathol. 2009 Mar;40(3):300-5
pubmed: 18992912
Clin Adv Hematol Oncol. 2016 May;14(5):346-56
pubmed: 27379696
Cancer. 2004 Jun 15;100(12):2543-8
pubmed: 15197794
Sign Transduct Insights. 2010;2:13-24
pubmed: 21687820
FEBS Lett. 2013 Jun 27;587(13):1959-69
pubmed: 23684648
Ultrastruct Pathol. 2012 Dec;36(6):381-6
pubmed: 23216236
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1196-205
pubmed: 21353161
Genomics. 1997 Oct 15;45(2):386-94
pubmed: 9344664
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6409-14
pubmed: 21464278
J Biol Chem. 2017 Jan 13;292(2):672-684
pubmed: 27909051
Biochemistry. 2015 Jul 21;54(28):4276-84
pubmed: 26098708
Cell Stress Chaperones. 2017 Jul;22(4):601-611
pubmed: 28364346
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
Drug Discov Today. 2012 Jan;17(1-2):35-43
pubmed: 21986108
Arch Toxicol. 2013 Jan;87(1):19-48
pubmed: 22885793
Histopathology. 2012 Sep;61(3):378-86
pubmed: 22463677
Exp Cell Res. 2006 Nov 1;312(18):3570-84
pubmed: 16979163
Cancer Lett. 1997 Jan 30;112(2):127-33
pubmed: 9066718
J Mol Biol. 2009 Oct 9;392(5):1242-52
pubmed: 19646995
Onco Targets Ther. 2019 May 30;12:4129-4139
pubmed: 31239701
Nat Struct Biol. 2001 Dec;8(12):1025-30
pubmed: 11702068
J Cancer Res Clin Oncol. 2011 Sep;137(9):1349-61
pubmed: 21833720
Oncogene. 2013 Jun 6;32(23):2900-6
pubmed: 22824795
Oncologist. 2019 Dec;24(12):e1409-e1416
pubmed: 31420467
J Biol Chem. 2001 May 11;276(19):16059-63
pubmed: 11274139
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20491-6
pubmed: 22143763
Prog Mol Biol Transl Sci. 2012;111:305-22
pubmed: 22917237
Mol Genet Genomic Med. 2019 Aug;7(8):e825
pubmed: 31215171
Cell. 2007 Aug 10;130(3):427-39
pubmed: 17693254
Clin Cancer Res. 2005 Aug 15;11(16):5678-85
pubmed: 16115903
Int J Cancer. 1993 Nov 11;55(5):760-4
pubmed: 8244572
FEBS Lett. 2013 Apr 17;587(8):1073-80
pubmed: 23340341
J Mol Biol. 2011 Aug 5;411(1):110-22
pubmed: 21641913
Breast Cancer Res Treat. 2010 Jan;119(1):63-70
pubmed: 19205872
Nat Struct Mol Biol. 2005 Oct;12(10):842-6
pubmed: 16205709
Development. 2015 Mar 1;142(5):994-1005
pubmed: 25715399
Free Radic Biol Med. 2015 Sep;86:331-42
pubmed: 26066304
J Breast Cancer. 2011 Mar;14(1):14-9
pubmed: 21847389
Int J Biochem Cell Biol. 2012 Oct;44(10):1622-31
pubmed: 22521623
Oncologist. 2017 Dec;22(12):1427-e129
pubmed: 28935773
Mol Cancer Res. 2011 Dec;9(12):1632-43
pubmed: 21984182
Oncotarget. 2011 Jul;2(7):557-61
pubmed: 21709317
Circ Res. 2003 Feb 7;92(2):130-2
pubmed: 12574138
Curr Opin Urol. 2013 May;23(3):194-200
pubmed: 23385973
Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3201-9
pubmed: 17873008
J Biochem. 2020 Aug 1;168(2):125-137
pubmed: 32725133
Exp Eye Res. 2004 Oct;79(4):577-83
pubmed: 15381041
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):E3780-9
pubmed: 24043785
Mol Cancer Ther. 2015 May;14(5):1107-16
pubmed: 25740245
Biochim Biophys Acta. 2015 Apr;1854(4):291-319
pubmed: 25556000
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10832-7
pubmed: 10995457
Cell Stress Chaperones. 2003 Spring;8(1):53-61
pubmed: 12820654
Cell Mol Life Sci. 2015 Nov;72(21):4127-37
pubmed: 26210153
J Biol Chem. 2005 Sep 30;280(39):33097-100
pubmed: 16076838
Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):251-4
pubmed: 21980040
Curr Mol Med. 2012 Nov 1;12(9):1164-73
pubmed: 22804239
Eur Urol. 2014 Jul;66(1):145-55
pubmed: 24411988
Clin Cancer Res. 2012 Jan 1;18(1):64-76
pubmed: 22215907
Int J Biochem Cell Biol. 2012 Oct;44(10):1706-10
pubmed: 22721753
Nat Rev Cancer. 2005 Jun;5(6):468-79
pubmed: 15905854
Nat Cell Biol. 2019 Apr;21(4):462-475
pubmed: 30886346
BMC Cancer. 2018 Jun 28;18(1):700
pubmed: 29954368
J Clin Invest. 2006 Jan;116(1):261-70
pubmed: 16395408
Cancer Cell. 2014 Mar 17;25(3):304-17
pubmed: 24651012
ACS Nano. 2011 May 24;5(5):3839-48
pubmed: 21517103
Mol Cell Biol. 1995 Dec;15(12):7081-90
pubmed: 8524275
J Biol Chem. 2004 Oct 22;279(43):44258-69
pubmed: 15284238

Auteurs

Daniela Caporossi (D)

Unit of Biology and Genetics of Movement, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Attilio Parisi (A)

Unit of Sport Medicine, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Cristina Fantini (C)

Unit of Biology and Genetics of Movement, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Elisa Grazioli (E)

Unit of Sport Medicine, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Claudia Cerulli (C)

Unit of Sport Medicine, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Ivan Dimauro (I)

Unit of Biology and Genetics of Movement, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy. ivan.dimauro@uniroma4.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH